Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Institute for Clinical and Experimental Medicine
National Cancer Center, Korea
Fujian Cancer Hospital
Tel-Aviv Sourasky Medical Center
The Royal Wolverhampton Hospitals NHS Trust
Lokman Hekim University
Dr. Lutfi Kirdar Kartal Training and Research Hospital
NHS Lothian
Vastra Gotaland Region
Lahore General Hospital
NHS Lothian
Henan Cancer Hospital
N.N. Alexandrov National Cancer Centre
Institut National de la Santé Et de la Recherche Médicale, France
Ankara Etlik City Hospital
Vastra Gotaland Region
Azienda USL Reggio Emilia - IRCCS
Turku University Hospital
Institut National de la Santé Et de la Recherche Médicale, France
Linkoeping University
Azienda USL Reggio Emilia - IRCCS
Ankara Etlik City Hospital
East and North Hertfordshire NHS Trust
Region Västerbotten
Västernorrland County Council, Sweden
Instituto Mexicano del Seguro Social
National Cancer Center, Korea
Zagazig University
Shanghai Public Health Clinical Center
Azienda USL Reggio Emilia - IRCCS
Azienda USL Reggio Emilia - IRCCS
Sykehuset Telemark
Ankara Etlik City Hospital
East and North Hertfordshire NHS Trust
East and North Hertfordshire NHS Trust
Region Västerbotten
Linkoeping University
Turku University Hospital
Anhui Provincial Hospital
Anhui Provincial Hospital
Anhui Provincial Hospital
Anhui Provincial Hospital
Jahn Ferenc South Pest Teaching Hospital
Ministry of Science and Technology of the People´s Republic of China
Turku University Hospital
Anhui Provincial Hospital
Henan Cancer Hospital
Dr. Lutfi Kirdar Kartal Training and Research Hospital
University Hospital, Angers
Anhui Provincial Hospital